According to the business/investing website The Motley Fool, the best selling drugs for 2013 are:
The combined sales of the top 5 drugs come in near 20 billion dollars. With 15.6 billion (79%) from the sales of biologics.
Using 2012 as baseline, Humira, Enbrel and Lantus were on the list of top selling biologics. But Remicade, Rituxan and Herceptin all placed higher than Avastin.
Which gets me thinking... did the fool.com author work off incomplete data?
- Humira (4.8B) - biologic
- Advair
- Enbrel (4.1B) - biologic
- Lantus (3.5B) - biologic
- Avastin (3.3B) - biologic
The combined sales of the top 5 drugs come in near 20 billion dollars. With 15.6 billion (79%) from the sales of biologics.Using 2012 as baseline, Humira, Enbrel and Lantus were on the list of top selling biologics. But Remicade, Rituxan and Herceptin all placed higher than Avastin.
Which gets me thinking... did the fool.com author work off incomplete data?
No comments:
Post a Comment